Glicaramide
 | |
| Systematic (IUPAC) name | |
|---|---|
| N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-1-ethyl-3-methyl-4-(3-methylbutoxy)pyrazolo[3,4-b]pyridine-5-carboxamide | |
| Clinical data | |
| Identifiers | |
| 36980-34-4 | |
| None | |
| PubChem | CID 65799 |
| ChemSpider | 59215 |
| UNII |
UK5SR22C8Q  |
| Chemical data | |
| Formula | C30H42N6O5S |
| 598.7567 g/mol | |
Glicaramide is a molecule which has anti-diabetic effects.[1] It has a similar potency as glibenclamide in the class of medication known as sulfonylureas. Its structure is similar since it has a cyclic acyl group which replaces the latter's 2-methoxy-5-chlorobenzyl.[2]
See also
References
- ↑ Hoehn, H.; Polacek, I.; Schulze, E. (1973). "Potential antidiabetic agents. Pyrazolo[3,4-b]pyridines". Journal of Medicinal Chemistry 16 (12): 1340–1346. doi:10.1021/jm00270a006. PMID 4358224.
- ↑ Progress in Medicinal Chemistry, Volume 18 (v. 18) (Hardcover). Elsevier Science. 1981. ISBN 0-444-80345-9.